Access cutting-edge breast cancer treatment through this clinical trial at a research site in Summit. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Summit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This study will evaluate the safety and efficacy of trastuzumab deruxtecan (T-DXd) in participants with human epidermal growth factor receptor 2 (HER2)-low or HER2 immunohistochemistry (IHC) 0 (who are both hormone receptor \[HR\]-negative and HR-positive) unresectable and/or metastatic breast cancer.
Sponsor: Daiichi Sankyo
Check if you qualify for this breast cancer clinical trial in Summit, NJ
If you're searching for breast cancer treatment options in Summit, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Summit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.